Literature DB >> 2683298

Pathologic basis of the sonographic appearance of the normal and malignant prostate.

K Shinohara1, P T Scardino, S S Carter, T M Wheeler.   

Abstract

The hypoechoic nature of prostatic cancer is now well recognized. In fact, not all cancers are purely hypoechoic; many are isoechoic, and some have a mixed echogenicity. Rarely, we have seen a cancer that was predominantly hyperechoic. Other signs of disturbance of the normal internal anatomy of the prostate may suggest the diagnosis of prostate cancer and are particularly valuable in assessing patients with more advanced disease. Approximately one third of early-stage cancers detected by palpation or transurethral resection are isoechoic. These tumors are anteriorly located, small, and well differentiated and infiltrate among normal glands or are composed of malignant glands similar in size to normal acini. Not all hypoechoic areas within the prostate are cancer; both normal anatomic structures and various benign conditions may appear less echogenic than the normal prostatic parenchyma. A comprehensive understanding of normal prostatic anatomy and the morphology of prostate cancer is essential to the accurate interpretation of the sonogram. Precise interpretation of prostatic sonograms requires detailed correlations of high-quality images with pathologic examinations of the whole prostate. The development of accurate criteria for the sonographic diagnosis of both malignant and benign prostatic diseases can be achieved only by such studies. As the possibilities and limitations of transrectal ultrasonography become apparent from pathologic correlation, the role of ultrasound in the diagnosis of prostate cancer will be placed on a more rational basis.

Entities:  

Mesh:

Year:  1989        PMID: 2683298

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  13 in total

1.  [Transrectal ultrasound of the prostate. Current status and prospects].

Authors:  M Zacharias; K V Jenderka; H Heynemann; P Fornara
Journal:  Urologe A       Date:  2002-11       Impact factor: 0.639

Review 2.  Periodic health examination, 1991 update: 3. Secondary prevention of prostate cancer. Canadian Task Force on the Periodic Health Examination.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

3.  Acoustic radiation force impulse imaging of human prostates ex vivo.

Authors:  Liang Zhai; John Madden; Wen-Chi Foo; Mark L Palmeri; Vladimir Mouraviev; Thomas J Polascik; Kathryn R Nightingale
Journal:  Ultrasound Med Biol       Date:  2010-04       Impact factor: 2.998

4.  Construction and application of hierarchical decision tree for classification of ultrasonographic prostate images.

Authors:  R J Giesen; A L Huynen; R G Aarnink; J J de la Rosette; F M Debruyne; H Wijkstra
Journal:  Med Biol Eng Comput       Date:  1996-03       Impact factor: 2.602

Review 5.  Artificial neural networks and prostate cancer--tools for diagnosis and management.

Authors:  Xinhai Hu; Henning Cammann; Hellmuth-A Meyer; Kurt Miller; Klaus Jung; Carsten Stephan
Journal:  Nat Rev Urol       Date:  2013-02-12       Impact factor: 14.432

Review 6.  Image guidance for focal therapy of prostate cancer.

Authors:  U Lindner; N Lawrentschuk; J Trachtenberg
Journal:  World J Urol       Date:  2010-10-21       Impact factor: 4.226

7.  Transrectal ultrasound guided biopsy of the prostate: random sextant versus biopsies of sono-morphologically suspicious lesions.

Authors:  Tillmann Loch; Ursula Eppelmann; Jan Lehmann; Bernd Wullich; Annemie Loch; Michael Stöckle
Journal:  World J Urol       Date:  2004-12-01       Impact factor: 4.226

8.  Screening for prostate cancer. How can patients give informed consent?

Authors:  K G Marshall
Journal:  Can Fam Physician       Date:  1993-11       Impact factor: 3.275

9.  Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.

Authors:  Tillmann Loch
Journal:  World J Urol       Date:  2007-08-11       Impact factor: 4.226

Review 10.  Screening for prostate cancer.

Authors:  M L Cher; P R Carroll
Journal:  West J Med       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.